These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 1662737)
21. Nasopharyngeal carcinoma: the diagnostic value of the antibody-dependent, cellular cytotoxicity test and of EBV serology. Faggioni A; Corradini C; Venanzoni M; Cardi G; Bevere F; Barile G; Zompetta C; Frati L J Exp Pathol; 1987; 3(4):471-7. PubMed ID: 2842480 [TBL] [Abstract][Full Text] [Related]
22. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma. Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805 [TBL] [Abstract][Full Text] [Related]
23. Epstein Barr virus (EBV) antibodies in the diagnosis of NPC--comparison between IFA and two commercial ELISA kits. Chan SH; Soo MY; Gan YY; Fones-Tan A; Sim PS; Kaur A; Chew CT Singapore Med J; 1998 Jun; 39(6):263-5. PubMed ID: 9803815 [TBL] [Abstract][Full Text] [Related]
24. [IgG and IgA antibodies to the Epstein-Barr virus and nasopharyngeal carcinoma]. Vera Sempere FJ Med Clin (Barc); 1992 May; 98(19):758-9. PubMed ID: 1318986 [No Abstract] [Full Text] [Related]
25. Serological and immunohistological assessment of Epstein-Barr virus infection in Sicilian patients with suspected nasopharyngeal carcinoma. Ammatuna P; de Thè G; Speciale R; Sammartano F; Arista S; Zerillo G Microbiologica; 1988 Apr; 11(2):89-94. PubMed ID: 2841559 [TBL] [Abstract][Full Text] [Related]
27. Expression of EBV antibody EA-IgA, Rta-IgG and VCA-IgA and SA in serum and the implication of combined assay in nasopharyngeal carcinoma diagnosis. Xia C; Zhu K; Zheng G Int J Clin Exp Pathol; 2015; 8(12):16104-10. PubMed ID: 26884888 [TBL] [Abstract][Full Text] [Related]
28. Serologic diagnosis of nasopharyngeal carcinoma. A double-blind study of four EB virus antibodies with evaluation by sequential discrimination. Cai WM; Li YW; Wu B; Liu YY; Hu YH; Gu XZ; Liu HY; Wang GD Int J Radiat Oncol Biol Phys; 1983 Dec; 9(12):1763-8. PubMed ID: 6319338 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus serological markers for nasopharyngeal carcinoma in Thailand. Puthavathana P; Sutthent R; Vitavasiri A; Wasi C; Chantarakul N; Thongcharoen P Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):326-31. PubMed ID: 1818381 [TBL] [Abstract][Full Text] [Related]
30. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients. Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351 [TBL] [Abstract][Full Text] [Related]
31. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma. Kaschka WP; Hilgers R; Skvaril F Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114 [TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma. Wong MM; Lye MS; Cheng HM; Sam CK Asian Pac J Allergy Immunol; 2005 Mar; 23(1):65-7. PubMed ID: 15997877 [TBL] [Abstract][Full Text] [Related]
33. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba. Ruiz R; Gurtsevich V; Le Riverend E Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic importance of heterophile antibodies and immunoglobulins IgA, IgE, IgM and low-avidity IgG against Epstein-Barr virus capsid antigen in children. Votava M; Bartosová D; Krchnáková A; Crhová K; Kubinová L Acta Virol; 1996 Apr; 40(2):99-101. PubMed ID: 8886119 [TBL] [Abstract][Full Text] [Related]
35. Detection and analysis of anti-latent membrane protein 2A antibodies in the sera of patients with Epstein-Barr virus associated malignancies. Chen Y; Yao K; Sun H; Qing J; Peng GY Chin Med J (Engl); 2005 May; 118(9):725-30. PubMed ID: 15899133 [TBL] [Abstract][Full Text] [Related]
36. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit]. Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576 [TBL] [Abstract][Full Text] [Related]
37. [A dynamic study on titer of EB virus VCA/IgA and EA/IgA in nasopharygeal carcinoma patients]. Ji MF; Guo YQ; Liang JS; Zheng SA; Cheng WM; Yu BH; Ou XT; Wang DK Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):243-5. PubMed ID: 12839685 [TBL] [Abstract][Full Text] [Related]
38. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Liu Y; Huang Q; Liu W; Liu Q; Jia W; Chang E; Chen F; Liu Z; Guo X; Mo H; Chen J; Rao D; Ye W; Cao S; Hong M Int J Cancer; 2012 Jul; 131(2):406-16. PubMed ID: 21866545 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic significance of combined detection of Epstein-Barr virus antibodies, VCA/IgA, EA/IgA, Rta/IgG and EBNA1/IgA for nasopharyngeal carcinoma. Cai YL; Li J; Lu AY; Zheng YM; Zhong WM; Wang W; Gao JQ; Zeng H; Cheng JR; Tang MZ Asian Pac J Cancer Prev; 2014; 15(5):2001-6. PubMed ID: 24716925 [TBL] [Abstract][Full Text] [Related]
40. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA]. Cai YL; Zheng YM; Cheng JR; Wang W; Zhang YN; Wang WH; Wu YS; Zhong WM; Li J; Mo YK Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):509-11. PubMed ID: 20335122 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]